Adapting drug approval pathways for bacteriophage-based therapeutics
The global rise of multi-drug resistant bacteria has resulted in the notion that an antibiotic apocalypse is fast approaching. This has led to a number of well publicized calls for global funding initiatives to develop new antibacterial agents. The long clinical history of phage therapy in Eastern...
Main Authors: | Callum Cooper, Mohammadali Khan Mirzaei, Anders S Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.01209/full |
Similar Items
-
Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
by: Frank Oechslin
Published: (2018-06-01) -
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
by: Lucy L. Furfaro, et al.
Published: (2018-10-01) -
Novel methods to design wild bacteriophages into highly lytic and therapeutic bacteriophages to extensively drug-resistant Mycobacterium tuberculosis
by: Ahmed S. Abdulamir
Published: (2016-10-01) -
Bacteriophage Production Models: An Overview
by: Rodrigo García, et al.
Published: (2019-06-01) -
Bacteriophages in Natural and Artificial Environments
by: Steven Batinovic, et al.
Published: (2019-07-01)